Literature DB >> 858034

Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.

R A Burt, T Morgan, J P Payne, R M Bonner.   

Abstract

Cinoxacin, a synthetic antibacterial compound, was given orally in a dose of 500 mg to 8 patients undergoing transurethral prostatectomy. The drug was well absorbed and the peak plasma level (mean 13.9 mcg/ml) occurred 1 or 2 hours after administration. Concentrations of cinoxacin in the urine reached a peak (mean 236.5 mcg/ml) 4 to 6 hours after dosing, and remained higher than the mean MIC for most common urinary pathogens for 12 hours after administration. The concentration of cinoxacin in prostatic tissue 2.5-4 hours after administration varied between 0.6 and 6.3 mcg/g. The individual variations were unrelated to the concurrent plasma level and appeared to be influenced more by inter-subject variation than by the physicochemical properties of the drug. In 1 patient the cinoxacin level was estimated in renal tissue (70.1 mcg/g), in muscle (12.6 mcg/g), and in perirenal fat (4.7 mcg/g).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 858034     DOI: 10.1111/j.1464-410x.1977.tb04089.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.

Authors:  J M Brogard; F Comte; J Lavillaureix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

2.  Pharmacology of cinoxacin in humans.

Authors:  H R Black; K S Israel; R L Wolen; G L Brier; B D Obermeyer; E A Ziege; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

Review 3.  Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.

Authors:  T S Sisca; R C Heel; J A Romankiewicz
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

4.  Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.

Authors:  S Maigaard; N Frimodt-Möller; P G Welling; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.